Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-02

Clinical Trial Update: Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Metamucil (psyllium husk) for effects on blood glucose and HbA1c in adults with type 2 diabetes mellitus was terminated, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metamucil (psyllium husk)

Snippet

Sponsor: Procter and Gamble | Conditions: Non-Insulin-dependent Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2012-11-02